Lennham Pharmaceuticals, Inc. — Form D
Lennham Pharmaceuticals, Inc. of CONCORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-04. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-04-04
- Form: D
- Accession: 0001104659-23-041280
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $1.2M
- Minimum investment: $50K
- Investors: 13
- Date of first sale: 2021-10-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-477817
Issuer
- Name: Lennham Pharmaceuticals, Inc.
- CIK: 0001853301
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 53 MAIN STREET, CONCORD, MA, 01742
- Phone: 617 388-7171
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Bradford C Sippy | Director | Concord, MA |
| Benjamin D Enerson | Executive Officer | Concord, MA |
| Corey D MacGregor | Executive Officer | Concord, MA |
| Bradford C Sippy | Executive Officer | Concord, MA |
Other filings by this issuer (1)
More